Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
- PMID: 10338516
- PMCID: PMC96617
- DOI: 10.1128/IAI.67.6.3031-3039.1999
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
Abstract
Citrobacter rodentium is a classically noninvasive pathogen of mice that is similar to enteropathogenic Escherichia coli (EPEC) in man. Following oral infection of young mice, the organism colonizes the distal colon, and within 1 week the colonic mucosa doubles in thickness and there is massive epithelial cell hyperplasia. Since T-cell responses in mouse models of inflammatory bowel disease (IBD) also cause epithelial hyperplasia, we have investigated the possibility that C. rodentium promotes similar T-cell responses in the mucosa, thereby increasing epithelial shedding, transmission, and replication of the organism. Beginning 6 days after infection, bacteria were observed to be in close association with the epithelial surface and were also visible scattered throughout the lamina propria and in the submucosa. There was a CD3(+)-cell infiltrate into the colonic lamina propria and epithelium as well as mucosal thickening and crypt hyperplasia. The majority of CD3(+) cells were CD4(+) and were not gammadelta+. Reverse transcription-PCR analysis of cytokines also revealed a highly polarized Th1 response (interleukin-12, gamma interferon, and tumor necrosis factor alpha) in the mucosa and a large increase in the epithelial cell mitogen keratinocyte growth factor. None of the changes were seen in mice inoculated with bacteria lacking intimin (which is necessary for colonization), but they were seen in mice inoculated with C. rodentium complemented with intimin from EPEC. This is the first example of a classically noninvasive bacterial pathogen which elicits a strong mucosal Th1 response and which produces pathology similar to that seen in mouse models of IBD, which is also characterized by a strong Th1 response. These results also suggest that the colonic mucosa responds in a stereotypic way to Th1 responses.
Figures
Similar articles
-
Citrobacter rodentium of mice and man.Cell Microbiol. 2005 Dec;7(12):1697-706. doi: 10.1111/j.1462-5822.2005.00625.x. Cell Microbiol. 2005. PMID: 16309456 Review.
-
Host defences to Citrobacter rodentium.Int J Med Microbiol. 2003 Apr;293(1):87-93. doi: 10.1078/1438-4221-00247. Int J Med Microbiol. 2003. PMID: 12755369 Review.
-
Intestinal pathogen or IBD, same T-cell response.Inflamm Bowel Dis. 2000 Feb;6(1):63-4. doi: 10.1097/00054725-200002000-00014. Inflamm Bowel Dis. 2000. PMID: 10701154 No abstract available.
-
Role of bacterial intimin in colonic hyperplasia and inflammation.Science. 1999 Jul 23;285(5427):588-91. doi: 10.1126/science.285.5427.588. Science. 1999. PMID: 10417389
-
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB.Infect Immun. 1996 Dec;64(12):5315-25. doi: 10.1128/iai.64.12.5315-5325.1996. Infect Immun. 1996. PMID: 8945583 Free PMC article.
Cited by
-
Distal colonocytes targeted by C. rodentium recruit T-cell help for barrier defence.Nature. 2024 May;629(8012):669-678. doi: 10.1038/s41586-024-07288-1. Epub 2024 Apr 10. Nature. 2024. PMID: 38600382 Free PMC article.
-
Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models.Front Immunol. 2023 Dec 19;14:1291990. doi: 10.3389/fimmu.2023.1291990. eCollection 2023. Front Immunol. 2023. PMID: 38179052 Free PMC article. Review.
-
TRPV1 controls innate immunity during Citrobacter rodentium enteric infection.PLoS Pathog. 2023 Dec 18;19(12):e1011576. doi: 10.1371/journal.ppat.1011576. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38109366 Free PMC article.
-
Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation.Front Immunol. 2023 Sep 7;14:1231700. doi: 10.3389/fimmu.2023.1231700. eCollection 2023. Front Immunol. 2023. PMID: 37744380 Free PMC article.
-
A Th17 cell-intrinsic glutathione/mitochondrial-IL-22 axis protects against intestinal inflammation.bioRxiv [Preprint]. 2023 Jul 7:2023.07.06.547932. doi: 10.1101/2023.07.06.547932. bioRxiv. 2023. PMID: 37489135 Free PMC article. Preprint.
References
-
- Ambrose N S, Johnson M, Burdon D W, Keighley M R B. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn’s disease surgery. Br J Surg. 1984;71:623–625. - PubMed
-
- Bajaj-Elliott M, Breese E, Poulsom R, Fairclough P D, MacDonald T T. Keratinocyte growth factor in inflammatory bowel disease: increased mRNA transcripts in ulcerative colitis compared with Crohn’s disease in biopsies and isolated mucosal myofibroblasts. Am J Pathol. 1997;151:1469–1476. - PMC - PubMed
-
- Barthold S W, Coleman G L, Bhatt P N, Osbaldiston G W, Jonas A M. The etiology of transmissable murine colonic hyperplasia. Lab Anim Sci. 1976;26:889–894. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials